comparemela.com

Latest Breaking News On - மருத்துவ ஆய்வகம் சோதனை - Page 1 : comparemela.com

Global Molecular Diagnostics for Infectious Disease Market 2021-2025: New Genotypes Creating New Markets / Aging Population a Boon for All Diagnostics / Developing World Driving ID Dx Growth

8.2.3 Wellness Hurts 8.3 Instrumentation and Automation 8.3.2 The Shrinking Machine 8.4 Diagnostic Technology Development 8.4.2 POCT/Self Testing as a Disruptive Force 8.4.3 The Genetics Play - One Test for All Known Infections 8.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics 9 Molecular Dx - Infectious Disease Recent Developments 9.1 Recent Developments - Importance and How to Use This Section 9.1.1 Importance of These Developments 9.1.2 How to Use This Section 9.2 Roche to Acquire GenMark Diagnostics for $1.8B 9.3 Lucira Health Focuses on User Friendly Approach to Home Testing 9.4 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO 9.5 Fluidigm Plans Durable Diagnostics, Clinical Business 9.6 Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

Worldwide OTC/DTC Infectious Disease Diagnostics Industry to 2025 - Privacy and Anonymity is Driving Growth

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development1 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test Lucira Health Files for $115M IPO Spectrum Solutions Gets CE Mark for Saliva Collection Devices Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit

Global Cancer Genomic Cancer Panel and Profiling (Germline/Somatic) Markets to 2025: Factors Driving Growth - Level of Care, Companion Dx, Immuno-oncology, Liability, Aging Population

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Metastatic Cancer Markers Identified in Clinical WGS Study Stitch Bio Bets on CRISPR Tech Bayer, LifeLabs Launch Free NTRK Genetic Testing Program Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Dx

Global Cancer Genomic Cancer Panel and Profiling (Germline/Somatic) Markets to 2025: Factors Driving Growth - Level of Care, Companion Dx, Immuno-oncology, Liability, Aging Population

Global Cancer Genomic Cancer Panel and Profiling (Germline/Somatic) Markets to 2025: Factors Driving Growth - Level of Care, Companion Dx, Immuno-oncology, Liability, Aging Population
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.